The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Resistance among Streptococcus pneumoniae:Implications for Drug Selection
Open accessAbstract
Streptococcus pneumoniae is an important pathogen in many community-acquired respiratory infections in the United States and a leading cause of morbidity and mortality worldwide. Unfortunately, S. pneumoniae is becoming increasingly resistant to a variety of antibiotics. Results of recent surveillance studies in the United States show that the prevalence of penicillin-nonsusceptible S. pneumoniae ranges from 25% to >50%, and rates of macrolide resistance among pneumococci are reported to be as high as 31%. A high prevalence of resistance to other antimicrobial classes is found among penicillin-resistant strains. Newer quinolones (e.g., gatifloxacin, gemifloxacin, and moxifloxacin) that have better antipneumococcal activity in vitro are the most active agents and therefore are attractive options for treatment of adults with community-acquired respiratory infections. Efforts should be made to prevent pneumococcal infections in high-risk patients through vaccination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Craig, W. A. (1998) · Clinical Infectious Diseases · doi:10.1086/516284 · Cited by 2,908
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
BLACK, S., SHINEFIELD, H., FIREMAN, B., LEWIS, E., RAY, P., HANSEN, J. R., ELVIN, L., ENSOR, K. M., HACKELL, J., SIBER, G., et al. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200003000-00003 · Cited by 2,293
Niederman, M. S., Mandell, L. A., Anzueto, A., Bass, J. B., Broughton, W. A., Campbell, G. D., Dean, N., File, T., Fine, M. J., Gross, P. A., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.7.at1010 · Cited by 2,150
Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis Media
Eskola, J., Kilpi, T., Palmu, A., Jokinen, J., Eerola, M., Haapakoski, J., Herva, E., Takala, A., Käyhty, H., Karma, P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102083440602 · Cited by 1,455
Holtzman, D. J., Powell‐Griner, E., Bolen, J. C., & Rhodes, L. (2000) · PubMed · Cited by 1,110
(1997) · PsycEXTRA Dataset · doi:10.1037/e547512006-001 · Cited by 1,000
Decreased Susceptibility of Streptococcus pneumoniae to Fluoroquinolones in Canada
Chen, D. K., McGeer, A., de Azavedo, J. C., & Low, D. E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907223410403 · Cited by 987
Community‐Acquired Pneumonia in Adults: Guidelines for Management
Bartlett, J. G., Breiman, R. F., Mandell, L. A., & File, Jr. (1998) · Clinical Infectious Diseases · doi:10.1086/513953 · Cited by 865
Emergence of Multiply Resistant Pneumococci
Jacobs, M. R., Koornhof, H. J., Robins-Browne, R. M., Stevenson, C. M., Vermaak, Z. A., Freiman, I., Miller, G. B., Witcomb, M. A., Isaäcson, M., Ward, J. I., et al. (1978) · New England Journal of Medicine · doi:10.1056/nejm197810052991402 · Cited by 630
Sutcliffe, J., Tait-Kamradt, A., & Wondrack, L. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.8.1817 · Cited by 619
Management of Infections Caused by Antibiotic-Resistant Streptococcus Pneumoniae
Wood, A. J. J., Friedland, I. R., & McCracken, G. H. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408113310607 · Cited by 578
Doern, G. V., Heilmann, K. P., Huynh, H. K., Rhomberg, P. R., Coffman, S. L., & Brueggemann, A. B. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1721-1729.2001 · Cited by 538
DOWELL, S. F., BUTLER, J. C., GIEBINK, G. S., JACOBS, M. R., JERNIGAN, D., MUSHER, D. M., RAKOWSKY, A., & SCHWARTZ, B. (1999) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199901000-00002 · Cited by 505
The Prevalence of Drug-Resistant Streptococcus pneumoniae In Atlanta
Hofmann, J., Cetron, M. S., Farley, M. M., Baughman, W. S., Facklam, R. R., Elliott, J. A., Deaver, K. A., & Breiman, R. F. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508243330803 · Cited by 503
Hansman, D., & Bullen, M. M. (1967) · The Lancet · doi:10.1016/s0140-6736(67)92346-x · Cited by 499
Arason, V. A., Kristinsson, K. G., Sigurdsson, J. A., Stefansdottir, G., Molstad, S., & Gudmundsson, S. (1996) · BMJ · doi:10.1136/bmj.313.7054.387 · Cited by 492
Doern, G. V., Brueggemann, A., Holley, H. P., & Rauch, A. M. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1208 · Cited by 482
Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae
Pan, X. S., Ambler, J., Mehtar, S., & Fisher, L. M. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2321 · Cited by 437
Pharmacokinetics and pharmacodynamics of antibiotics in otitis media
CRAIG, W. A., & ANDES, D. (1996) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199603000-00015 · Cited by 435
Doern, G. V., Pfaller, M. A., Kugler, K., Freeman, J., & Jones, R. N. (1998) · Clinical Infectious Diseases · doi:10.1086/514953 · Cited by 386
Butler, J. C., Hofman, J., Cetron, M. S., Elliott, J. A., Facklam, R. R., Breiman, R. F., & Pneumococcal Sentinel Surveillance Working Group (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.5.986 · Cited by 341
Jacobs, M. R., Bajaksouzian, S., Zilles, A., Lin, G., Pankuch, G. A., & Appelbaum, P. C. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.1901 · Cited by 317
Self-citationMacrolide Resistance Among Invasive <EMPH TYPE="ITAL">Streptococcus pneumoniae</EMPH> Isolates
Hyde, T. B. (2001) · JAMA · doi:10.1001/jama.286.15.1857 · Cited by 315
Jorgensen, J. H., Doern, G. V., Maher, L. A., Howell, A. W., & Redding, J. S. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.11.2075 · Cited by 310
Mechanisms of Fluoroquinolone Resistance: An Update 1994-1998
Piddock, L. J. V. (1999) · Drugs · doi:10.2165/00003495-199958002-00003 · Cited by 308
Tait-Kamradt, A., Davies, T., Appelbaum, P. C., Depardieu, F., Courvalin, P., Petitpas, J., Wondrack, L., Walker, A., Jacobs, M. R., & Sutcliffe, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3395-3401.2000 · Cited by 260
Self-citationGill, M. J., Brenwald, N. P., & Wise, R. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.1.187 · Cited by 259
Song, J., Lee, N. Y., Ichiyama, S., Yoshida, R., Hirakata, Y., Fu, W., Chongthaleong, A., Aswapokee, N., Chiu, C., Lalitha, M. K., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/514783 · Cited by 258
Self-citationPfaller, M. A., Jones, R. N., Doern, G. V., Sader, H. S., Kugler, K. C., & Beach, M. L. (1999) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(98)00149-7 · Cited by 243
Ho, P.-L., Que, T.-L., Tsang, D. N.-C., Ng, T.-K., Chow, K.-H., & Seto, W.-H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1310 · Cited by 241
Breakthrough Pneumococcal Bacteremia in Patients Being Treated with Azithromycin and Clarithromycin
Kelley, M. A., Weber, D. J., Gilligan, P., & Cohen, M. S. (2000) · Clinical Infectious Diseases · doi:10.1086/318157 · Cited by 234
Janoir, C., Zeller, V, Kitzis, M. D., Moreau, N. J., & Gutmann, L. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.12.2760 · Cited by 232
Muñoz, R., & De La Campa, A. G. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2252 · Cited by 226
Pharmacodynamics of Fluoroquinolones
Lode, H., Borner, K., & Koeppe, P. (1998) · Clinical Infectious Diseases · doi:10.1086/514623 · Cited by 220
Lacy, M. K., Lu, W., Xu, X., Tessier, P. R., Nicolau, D. P., Quintiliani, R., & Nightingale, C. H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.3.672 · Cited by 219
Felmingham, D., Washington, J., & Group, T. A. P. (1999) · Journal of Chemotherapy · doi:10.1179/joc.1999.11.supplement-2.5 · Cited by 185
Ketolides lack inducibility properties of MLS(B) resistance phenotype
Bonnefoy, A. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.85 · Cited by 183
Shortridge, V. D., Doern, G. V., Brueggemann, A. B., Beyer, J. M., & Flamm, R. K. (1999) · Clinical Infectious Diseases · doi:10.1086/313452 · Cited by 178
McDougal, L. K., Facklam, R., Reeves, M., Hunter, S., Swenson, J. M., Hill, B. C., & Tenover, F. C. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.10.2176 · Cited by 176
Tankovic, J., Perichon, B., Duval, J., & Courvalin, P. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.11.2505 · Cited by 174
New Uses for New and Old Quinolones and the Challenge of Resistance
Hooper, D. C. (2000) · Clinical Infectious Diseases · doi:10.1086/313677 · Cited by 171
Antimicrobial Treatment Guidelines for Acute Bacterial Rhinosinusitis
(2000) · Otolaryngology · doi:10.1067/mhn.2000.107873 · Cited by 150
Burdett, V (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)49928-0 · Cited by 141
McCullers, J. A., English, B. K., & Novak, R. (2000) · The Journal of Infectious Diseases · doi:10.1086/315216 · Cited by 133
Adrian, P. V., & Klugman, K. P. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.11.2406 · Cited by 132
Gay, K., Baughman, W., Miller, Y. K., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315853 · Cited by 126
The evolving threat of antibiotic resistance in Europe: new data from the Alexander Project
Schito, G. C., Debbia, E. A., & Marchese, A. E. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/oxfordjournals.jac.a020891 · Cited by 123
Bradley, J. S., & Scheid, W. M. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_2.s213 · Cited by 103
Reichmann, P., König, A. A., Liñares, J., Alcaide, F., Tenover, F. C., McDougal, L. K., Swidsinski, S., & Hakenbeck, R. (1997) · The Journal of Infectious Diseases · doi:10.1086/516532 · Cited by 99
Markiewicz, Z., & Tomasz, A. (1989) · Journal of Clinical Microbiology · doi:10.1128/jcm.27.3.405-410.1989 · Cited by 96
Davies, T. A., Pankuch, G. A., Dewasse, B. E., Jacobs, M. R., & Appelbaum, P. C. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1177 · Cited by 84
Self-citationA New Ketolide, HMR 3004, Active against Streptococci Inducibly Resistant to Erythromycin
Rosato, A. E., Vicarini, H., Bonnefoy, A., Chantot, J., & Leclercq, R. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.6.1392 · Cited by 70
File, T. M. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.1.67 · Cited by 66
Prevalence and Resistance Mechanisms of Common Bacterial Respiratory Pathogens
Jacoby, G. A. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.6.951 · Cited by 66
Sherman, B. E., & Chole, R. A. (2000) · Otolaryngology · doi:10.1067/mhn.2000.105996 · Cited by 37
Davies, T. A., Goering, R. V., Lovgren, M., Talbot, J., Jacobs, M. R., & Appelbaum, P. C. (1999) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(98)00156-4 · Cited by 29
Self-citationPotgieter, E., & Chalkley, L. J. (1995) · Microbial Drug Resistance · doi:10.1089/mdr.1995.1.35 · Cited by 25
Cited by
The quinolones: decades of development and use
Emmerson, A. M. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg208 · Cited by 531
Dysregulation of bacterial proteolytic machinery by a new class of antibiotics
Brötz-Oesterhelt, H., Beyer, D., Kroll, H.-P., Endermann, R., Ladel, C., Schroeder, W., Hinzen, B., Raddatz, S., Paulsen, H., Henninger, K., et al. (2005) · Nature Medicine · doi:10.1038/nm1306 · Cited by 505
Lanie, J. A., Ng, W.-L., Kazmierczak, K. M., Andrzejewski, T. M., Davidsen, T. M., Wayne, K. J., Tettelin, H., Glass, J. I., & Winkler, M. E. (2007) · Journal of Bacteriology · doi:10.1128/jb.01148-06 · Cited by 443
Fluoroquinolones, tuberculosis, and resistance
Ginsburg, A. S., Grosset, J. H., & Bishai, W. R. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00671-6 · Cited by 403
Advances in treatment of bacterial meningitis
van de Beek, D., Brouwer, M. C., Thwaites, G. E., & Tunkel, A. R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61186-6 · Cited by 336
Metadata
- Authors
- Appelbaum, P. C.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-06-15
- Volume
- 34
- Issue
- 12
- Pages
- 1613-1620
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2143391752
- Cited by
- 260
- References
- 58
- FWCI
- 21.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.